Product image of Glucos Fresenius Kabi (Glucose) supplied by GNH India

Glucos Fresenius Kabi

Active Ingredient:
Glucose
Origin:
EU

Glucos Fresenius Kabi (Glucose)

Glucos Fresenius Kabi is an intravenous solution for injection that contains glucose as the sole active ingredient. The product is supplied in a sterile liquid form, intended for parenteral administration, and is marketed in the European Union for use under prescription. It provides an immediate source of carbohydrate energy and assists in fluid and electrolyte management during clinical care.

Manufacturer / TM Owner

Fresenius Kabi Norge As

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucos Fresenius Kabi is indicated for several clinical situations where rapid glucose supplementation or fluid replacement is required. It is commonly employed in hospital settings for patients who cannot receive oral nutrition.

  • Treatment of hypoglycemia in emergency or perioperative settings
  • Component of parenteral nutrition regimens for patients requiring intravenous caloric support
  • Fluid and electrolyte replacement in dehydration or postoperative care
  • Maintenance of plasma osmolarity during intravenous therapy
  • Support for patients undergoing dialysis or continuous renal replacement therapy

Side Effects

Glucos Fresenius Kabi is generally well tolerated when administered according to clinical guidelines. Adverse reactions may vary in frequency and severity.

Common

  • Local irritation at the infusion site
  • Mild hyperglycemia
  • Transient electrolyte imbalance (e.g., sodium, potassium)
  • Nausea or vomiting
  • Headache
  • Flushing or warmth sensation

Serious

  • Severe hyperglycemia leading to osmotic diuresis
  • Allergic reaction such as urticaria or anaphylaxis
  • Volume overload causing pulmonary edema
  • Metabolic acidosis in susceptible patients

Precautions & Warnings

When using Glucos Fresenius Kabi, clinicians should assess patient-specific factors and monitor relevant parameters to minimize risks.

  • Verify blood glucose levels before and during infusion to avoid hyperglycemia
  • Adjust infusion rate in patients with renal or cardiac insufficiency to prevent fluid overload
  • Use caution in diabetic patients or those on insulin therapy
  • Monitor electrolytes, especially sodium and potassium, during prolonged administration
  • Ensure compatibility with other intravenous solutions to avoid precipitation
  • Observe for signs of infection at the catheter site

Avoid Interactions

Glucos Fresenius Kabi may interact with other medications or clinical conditions, influencing its safety profile.

Avoid

  • Concurrent administration with high‑dose insulin without glucose monitoring
  • Co‑infusion with calcium-containing solutions that may precipitate
  • Use in patients with severe hyperglycemia untreated

Use with caution

  • Diuretics that affect electrolyte balance
  • Beta‑blockers that mask hypoglycemia symptoms
  • Corticosteroids that increase glucose production
  • Anticoagulants if large fluid volumes are infused rapidly

Frequently Asked Questions

Glucos Fresenius Kabi is primarily indicated for the treatment of hypoglycemia and as a component of parenteral nutrition to provide intravenous carbohydrate calories.

The product is administered intravenously as a sterile solution for injection, typically through a peripheral or central venous catheter under medical supervision.

Use in pediatric patients is possible but requires dose adjustment and close monitoring of blood glucose and fluid status by a qualified healthcare professional.

Blood glucose levels, electrolyte concentrations, and fluid balance should be monitored regularly to detect hyperglycemia, electrolyte shifts, or volume overload.

Compatibility depends on the specific medication; it is generally compatible with many IV solutions but may precipitate when mixed with calcium-containing products.

Signs may include rash, itching, swelling, difficulty breathing, or anaphylaxis, and require immediate medical attention.

The solution should be stored at controlled room temperature, protected from light, and used before the expiration date indicated on the packaging.

It can contribute to fluid resuscitation, but clinicians often combine it with other crystalloid solutions to meet specific volume and electrolyte requirements.

Glucose provides an immediate source of energy for cellular metabolism and helps maintain plasma osmolarity when delivered intravenously.

Contraindications include untreated severe hyperglycemia, known hypersensitivity to glucose solutions, and conditions where fluid overload would be hazardous.

Glucos Fresenius Kabi is supplied as a sterile solution for injection; specific concentrations may vary by market and are defined by the prescribing information.

Yes, Glucos Fresenius Kabi is classified as a prescription‑only (Rx) product and must be administered under the direction of a qualified healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glucose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT